Medical complications of obesity: heightened importance in a COVID era.
Cancer
Dementia
Dyslipidemia
Hypertension
Non-alcoholic fatty liver disease
Obesity
Polycystic ovarian syndrome
Type 2 diabetes
Journal
International journal of emergency medicine
ISSN: 1865-1372
Titre abrégé: Int J Emerg Med
Pays: England
ID NLM: 101469435
Informations de publication
Date de publication:
23 Jun 2022
23 Jun 2022
Historique:
received:
21
09
2021
accepted:
08
05
2022
entrez:
23
6
2022
pubmed:
24
6
2022
medline:
24
6
2022
Statut:
epublish
Résumé
Obesity is a major public health problem associated with significant medical complications. This review examines 8 primary diseases: type 2 diabetes, hypertension, dementia, non-alcoholic fatty liver disease, polycystic ovarian syndrome, dyslipidemia, cancer, and their manifestations in obese patients. A total of 39 articles were used for this review. The authors conducted limited review, searching PubMed and Google Scholar databases using a combination of key words "COVID-19" or "SARS-COV2", "type 2 diabetes", "hypertension", "dementia", "non-alcoholic fatty liver disease", "polycystic ovarian syndrome", "dyslipidemia", "cancer", and "obesity". No specific date limitation was used. Obesity exacerbates many medical conditions and has recently been identified as an independent risk factor for COVID-19 severity. This sets obesity at the pinnacle of all disease complications. The long-term impact of obesity ranges from financial burden on the health system, lower life expectancy, and reduced survival rates. Obesity is an important modifiable risk factor. There is the need for healthcare providers to understand the medical complications associated with obesity to optimize patient care.
Sections du résumé
BACKGROUND
BACKGROUND
Obesity is a major public health problem associated with significant medical complications.
MAIN BODY
METHODS
This review examines 8 primary diseases: type 2 diabetes, hypertension, dementia, non-alcoholic fatty liver disease, polycystic ovarian syndrome, dyslipidemia, cancer, and their manifestations in obese patients. A total of 39 articles were used for this review. The authors conducted limited review, searching PubMed and Google Scholar databases using a combination of key words "COVID-19" or "SARS-COV2", "type 2 diabetes", "hypertension", "dementia", "non-alcoholic fatty liver disease", "polycystic ovarian syndrome", "dyslipidemia", "cancer", and "obesity". No specific date limitation was used. Obesity exacerbates many medical conditions and has recently been identified as an independent risk factor for COVID-19 severity. This sets obesity at the pinnacle of all disease complications. The long-term impact of obesity ranges from financial burden on the health system, lower life expectancy, and reduced survival rates.
CONCLUSION
CONCLUSIONS
Obesity is an important modifiable risk factor. There is the need for healthcare providers to understand the medical complications associated with obesity to optimize patient care.
Identifiants
pubmed: 35739488
doi: 10.1186/s12245-022-00431-7
pii: 10.1186/s12245-022-00431-7
pmc: PMC9219148
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
29Informations de copyright
© 2022. The Author(s).
Références
Clin Infect Dis. 2020 Jul 28;71(15):896-897
pubmed: 32271368
Acute Med. 2012;11(2):107-12
pubmed: 22685701
Diabetes Res Clin Pract. 2020 Aug;166:108331
pubmed: 32682810
QJM. 2006 Sep;99(9):565-79
pubmed: 16916862
SN Compr Clin Med. 2020;2(8):1045-1047
pubmed: 32838154
Horm Metab Res. 2021 Feb;53(2):85-93
pubmed: 33395706
Obes Manag. 2007 Apr;3(2):69-73
pubmed: 20436797
PLoS One. 2020 Dec 22;15(12):e0238552
pubmed: 33351817
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jun 24;48(6):450-455
pubmed: 32120458
Mayo Clin Proc. 2020 Sep;95(9):2040-2042
pubmed: 32861346
Diabetes Care. 2016 Jan;39 Suppl 1:S47-51
pubmed: 26696681
Lancet. 2020 Jun 6;395(10239):1763-1770
pubmed: 32442528
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199
pubmed: 32271993
JAMA. 2015 Sep 8;314(10):1052-62
pubmed: 26348754
Oncologist. 2010;15(6):556-65
pubmed: 20507889
Care Manag J. 2015;16(1):14-9
pubmed: 25918773
Adolesc Health Med Ther. 2015 Oct 21;6:171-87
pubmed: 26543386
Hepatology. 2010 Feb;51(2):679-89
pubmed: 20041406
Nutrients. 2013 Apr 12;5(4):1218-40
pubmed: 23584084
Diabetes Care. 2020 Jul;43(7):1392-1398
pubmed: 32409502
JAMA. 2003 Jun 11;289(22):3000-4
pubmed: 12799409
Infect Dis Poverty. 2020 Jun 29;9(1):80
pubmed: 32600411
Prim Care Diabetes. 2020 Oct;14(5):566-567
pubmed: 32493608
Endocrinol Diabetes Metab. 2020 Aug 14;4(1):e00176
pubmed: 32904932
Metabolism. 2021 Apr;117:154703
pubmed: 33421506
BMJ Open Respir Res. 2020 Dec;7(1):
pubmed: 33328246
Trends Cardiovasc Med. 2016 May;26(4):364-73
pubmed: 26654259
Clin Chim Acta. 2015 Oct 23;450:162-8
pubmed: 26279362
Biochim Biophys Acta. 2016 May;1862(5):966-74
pubmed: 26546479
Int J Gen Med. 2010 Oct 20;3:335-43
pubmed: 21116339
Obesity (Silver Spring). 2020 Aug;28(8):1382-1385
pubmed: 32352652